Metabolism in the Gastrointestinal Tract: Relevance for Drug Development

Maximilian Feldmüller; Joachim Höchel

doi:10.1055/a-1606-5476

Drug Research, Table of Contents

Drug Res (Stuttg) 2021; 71(S 01): S8-S10
DOI: 10.1055/a-1606-5476

Extended Abstract

Metabolism in the Gastrointestinal Tract: Relevance for Drug Development

Maximilian Feldmüller

,

Joachim Höchel

Abstract

Full Text

References

References
1 Yamahara H, Lee VHL. Drug metabolism in the oral cavity. Advanced Drug Delivery Reviews 1993; 12: 25-40
2 Finn A, Collins J, Voyksner R. et al. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route. J Clin Pharmacol 2005; 45: 1383-1390
3 Smart JD. Buccal drug delivery. Expert Opin Drug Deliv 2005; 2: 507-517
4 Li Q, Castell JA, Castell DO. Manometric determination of esophageal length. Am J Gastroenterol 1994; 89: 722-725
5 Batchelor H. Bioadhesive dosage forms for esophageal drug delivery. Pharmaceutical Research 2005; 22: 175-181
6 Dellon ES, Sheikh A, Speck O. et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology 2012; 143: 321-324
7 De Groen PC, Luebbe DF, Hirsch LF. et al. Esophagitis associated with the use of alendronate. N Engl J Med 1996; 14: 1016-1021
8 Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997; 32: 3-9
9 George CF. Drug Metabolism by the gastrointestinal mucosa. Clin Pharmacokinet 1981; 6: 259-274
10 Back DJ, Roger SM. Review : first-pass metabolism by the gastrointestinal mucosa. Aliment Pharmacol Therap 1987; 1: 339-357
11 Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994; 26: 144-160
12 Paine MF, Shen DD, Kunze KL. et al. First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 1996; 60: 14-24
13 Aldwell JH, Bush CA, Greenberger NJ. Interruption of the enterohepatic circulation of digitoxin by cholestyramine: II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. J Clin Invest 1971; 12: 2638-2644
14 Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-193
15 Rekdal VM, EN. Bisanz JE. et al. Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science 2019; 364: eaau6323
16 Consortium, Human Microbiome Project. Structure, function and diversity of the healthy human microbiom. Nature 2012; 486: 207-214
17 Sun C, Chen L, Shen Z. Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharm J 2019; 8: 1146-1156
18 Schroder H, Campbell DES. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972; 13: 539-551
19 Wilkinson G. Drug Metabolism and variability among patients in drug response. N Engl J Med 2005; 352: 2211-2221